Head and Neck Cancer Registry (LORHAN)

Completed

Conditions studied: Head and Neck Cancer

In brief

The primary objective of this study is to describe, in detail, patterns of care for head and neck carcinoma patient

Key facts

Study ID

NCT01080313

Run by

Eli Lilly and Company

People needed

26000

Starts

2005-08-01

Expected to finish

2011-12-01

Last updated by the study team

2012-02-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Pathologically (histologically or cytologically) confirmed new diagnosis of carcinoma involving the oral cavity, oropharynx, nasopharynx, hypopharynx, larynx, or neck node metastasis from unknown origin
• Scheduled to receive radiotherapy and/or drug therapy including chemotherapy, biologic therapy and targeted therapy
• Written informed consent

You may not qualify if…

• Registry participation does not exclude participation in clinical trials.
• Patients scheduled to receive or who have received surgery are eligible for Registry participation as long as they are also scheduled to receive medical therapy.

Where it is running

• Mednet Solutions — Minnetonka, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.